Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05838768
Title	Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Novartis Pharmaceuticals
Indications	Advanced Solid Tumor
Therapies	HRO761 HRO761 + Tislelizumab HRO761 + Irinotecan
Age Groups:	adult \| senior
Covered Countries	USA \| SWE \| NOR \| ITA \| ISR \| FRA \| ESP \| DEU \| BEL